Dr James Davison

Dr James Davison is a distinguished Consultant Paediatrician and Consultant in Paediatric Metabolic Medicine, dedicated to providing compassionate, patient-centred care for children and young people. Specialising in inherited metabolic disorders, he brings extensive clinical expertise to diagnosing and managing rare, complex metabolic conditions in young patients. His clinical scope encompasses all areas of paediatric metabolic medicine, with a particular focus on lysosomal storage disorders and organelle-based metabolic diseases. Dr Davison works closely with multidisciplinary teams to deliver individualised treatment plans tailored to the distinct health and developmental needs of every child.

Dr Davison completed his undergraduate medical degree and postgraduate paediatric training in Birmingham and the West Midlands. He subsequently earned his Doctor of Philosophy (PhD), conducting doctoral research into functional brain imaging in children with metabolic conditions and developing non-invasive brain chemical profiling techniques using quantitative magnetic resonance spectroscopy. A Fellow of the Royal College of Paediatrics and Child Health (FRCPCH), Dr Davison remains actively engaged in medical leadership and professional education. He serves as Chair of the British Inherited Metabolic Diseases Group (BIMDG) and is a member of the Education and Training Committee for the Society for the Study of Inborn Errors of Metabolism (SSIEM). In addition, he contributes his expertise as a clinical advisor for national appraisal processes and serves on key drug and therapeutics committees.

In his ongoing clinical practice, Dr Davison manages a comprehensive array of paediatric metabolic conditions, including neurometabolic diseases, mitochondrial disorders, peroxisomal conditions, organic acidurias, urea cycle defects, and metabolic liver disease. He is deeply invested in expanding early diagnostic capabilities through newborn screening programmes, as well as advancing innovative clinical trials for emerging treatments. His research work includes evaluating novel interventional therapies, such as enzyme replacement therapy and targeted genetic treatments for conditions like Pompe disease and Hunter syndrome. Dr Davison is committed to an open, supportive approach that reassures families while delivering evidence-based medical care.